Stay updated with breaking news from Ben Halladay. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Esperion Therapeutics, Inc. (NASDAQ:ESPR) Q4 2023 Earnings Call Transcript February 27, 2024 Esperion Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.5, expectations were $-0.53. Esperion Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, ladies and […]
Esperion Therapeutics, Inc. (NASDAQ:ESPR) Q3 2023 Earnings Call Transcript November 7, 2023 Esperion Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.37, expectations were $-0.42. Operator: Ladies and gentlemen, thank you for standing by and welcome to Esperion Therapeutics Third Quarter 2023 financial results call. At this time, all participants are in a lisen-only mode. […]
To commemorate Bourbon month, we recently sat down with noted whiskey expert Fred Minnick to talk about the state of bourbon in America
ANN ARBOR, Mich., July 24, 2023 -- Esperion today announced its participation in the BTIG Virtual Biotechnology Conference 2023. Ben Halladay, Chief Financial Officer, will participate in a...
ANN ARBOR, Mich., Nov. 16, 2022 -- Esperion today announced that Ben Halladay, MBA, has been promoted to the role of Chief Financial Officer from his prior position of Senior Director, Financial... | November 16, 2022